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ABSTRACT
Purpose: Dose assessment intercomparisons within the RENEB network were performed for triage bio-
dosimetry analyzing G0-lymphocyte PCC for harmonization, standardization and optimization of the
PCC assay.
Materials and methods: Comparative analysis among different partners for dose assessment included
shipment of PCC-slides and captured images to construct dose-response curves for up to 6Gy c-rays.
Accident simulation exercises were performed to assess the suitability of the PCC assay by detecting
speed of analysis and minimum number of cells required for categorization of potentially exposed
individuals.
Results: Calibration data based on Giemsa-stained fragments in excess of 46 PCC were obtained by
different partners using galleries of PCC images for each dose-point. Mean values derived from all
scores yielded a linear dose-response with approximately 4 excess-fragments/cell/Gy. To unify scoring
criteria, exercises were carried out using coded PCC-slides and/or coded irradiated blood samples.
Analysis of samples received 24h post-exposure was successfully performed using Giemsa staining
(1 excess-fragment/cell/Gy) or centromere/telomere FISH-staining for dicentrics.
Conclusions: Dose assessments by RENEB partners using appropriate calibration curves were mostly in
good agreement. The PCC assay is quick and reliable for whole- or partial-body triage biodosimetry by
scoring excess-fragments or dicentrics in G0-lymphocytes. Particularly, analysis of Giemsa-stained excess
PCC-fragments is simple, inexpensive and its automation could increase throughput and scoring
objectivity of the PCC assay.
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Introduction
In case of radiological emergency, a considerable number of
individuals may be exposed to a wide distribution of doses
and, therefore, there is an immediate need to predict clinic-
ally relevant responses based on quick and accurate triage
biodosimetry methods. The ‘gold standard’ cytogenetic
approach (dicentric analysis at metaphase) presupposes
lymphocyte stimulation and a two-day culture, failing
thus the criterion for rapid dose estimation, which is a
high priority in radiation emergency medicine. To overcome
this shortcoming, the analysis of radiation-induced
chromosomal aberrations in non-stimulated G0-peripheral
blood lymphocytes for biodosimetry by means of their fusion
with Chinese Hamster Ovary (CHO) mitotic cells using poly-
ethylene glycol (PEG) was first introduced by Pantelias and
Maillie (1983, 1984, 1985a). Specifically, this PCC assay
allowed rapid quantification of an exposure by means of the
analysis of fragments and rings using Giemsa stain (Pantelias
& Maillie 1985a, 1985b; Lamadrid Boada et al. 2013).
Subsequently, the PCC assay in combination with the centro-
meric (C-banding) technique or with the fluorescence in situ
hybridization (FISH) methodology was used for the analysis
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of dicentric chromosomes and translocations directly in G0-
lymphocyte prematurely condensed chromosomes (PCC)
(Vyas et al. 1991; Pantelias et al. 1993; Durante et al. 1996;
Darroudi et al. 1998a). Furthermore, the PCC assay was also
applied successfully to assess whole and partial body expos-
ure in vivo following irradiation of monkeys (Darroudi et al.
1998b). In addition, Fomina et al. (2000, 2001) developed and
reported on a combination of staining all human centro-
meres and telomeres with chromosome paint probes in
metaphases, in order to assess accurately different types of
structural chromosomal aberrations in human lymphocytes,
following exposure to radiation of different qualities.
Recently, in order to score dicentric and centric ring chromo-
somes directly in G0-lymphocyte PCC with a level of accuracy
not possible previously, the development of centromeric/
telomeric (C/T) peptide nucleic acid (PNA) probes in combin-
ation with FISH (C/T FISH staining), has offered a new
dynamic to the PCC assay (Karachristou et al. 2015; M’Kacher
et al. 2015; Suto et al. 2015).
Yet, despite its advantages, dose assessment of an expos-
ure by means of the PCC assay is not at present widely used.
In the present work and in the framework of Realizing the
European Network of Biodosimetry (RENEB), dose assessment
intercomparisons within the RENEB network were carried out
performing inter-laboratory exercises using unstimulated
blood lymphocyte PCC for harmonization, standardization
and optimization of the PCC assay for its use in case of radio-
logical emergency. The experimental design for comparative
analysis among the different partners included shipment of
PCC slides and galleries of captured images for different
doses up to 6Gy gamma rays in order to obtain calibration
data to be used during programmed intercomparisons.
Specifically, to unify the PCC methodology and scoring crite-
ria, exercises were carried out among RENEB partners using
coded PCC-slides and/or coded irradiated blood samples.
Accident simulation exercises for whole or partial body
exposure were also carried out. Coded irradiated blood sam-
ples or slides were sent to the participating laboratories and
analysed in order to assess the suitability of the PEG-medi-
ated cell fusion PCC assay for the rapid categorization of
potentially exposed individuals. Overall, the results obtained
from the dose assessment intercomparisons showed good
agreement within the RENEB network and suggested that
the cell fusion PCC assay has the characteristics and potential
to become a quick and reliable approach for triage biodosim-
etry in case of large-scale radiological emergencies.
Materials and methods
Taking into consideration that the PCC assay is technically
demanding and not yet widely used, a detailed protocol for
PEG-mediated cell fusion and PCC induction in lymphocytes
isolated from the peripheral blood using mitotic CHO cells
was established by the L1 laboratory and shared with the
RENEB partners, in order to harmonize and standardize the
PCC assay as well as the scoring criteria. Informed consent
was obtained for each blood donor, and packaging, labelling
and shipment of blood samples conformed to national and
international regulations. A temperature logger, dosimeter to
record the temperature and any dose received by the sam-
ples during transport, was used together with the standar-
dized sample instruction sheet (ISO21243 2008; ISO19238
2014). The peripheral blood was always sampled in hepari-
nized vials and, for the isolation of lymphocytes, whole blood
was carefully layered on top of equal amount of Ficoll-Paque
or Biocoll gradient (Biochrom) in a test tube before centrifu-
gation. In order to quantitate radiation exposure by means of
initially induced PCC fragments, the PCC methodology was
applied as soon as possible, since the initial radiation-
induced fragments in excess of 46 PCC decrease with time
(Pantelias & Maillie 1985a; Darroudi et al. 1998a).
Cell cultures and irradiation conditions
Chinese hamster Ovary (CHO) cells were grown in McCoy’s
5A (Biochrom), culture medium supplemented with 10% FBS,
1% l-glutamine and antibiotics (penicillin: 100U/ml; strepto-
mycin: 100 g/ml), incubated at 37 C in a humidified atmos-
phere with 5% CO2. CHO cultures were maintained as
exponentially growing monolayer cultures in 75 cm2 plastic
flasks at an initial density of 4 105 cells/flask. Colcemid
(Gibco) at a final concentration of 0.1 lg/ml was added to
CHO cultures for 4 h and the accumulated mitotic cells were
harvested by selective detachment. Once a sufficient number
of mitotic cells had been obtained, they were used as mitotic
promoting factors (MPF) supplier to induced PCC in human
lymphocytes. Irradiation was carried out in a Gamma Cell 220
irradiator (Atomic Energy of Canada Ltd, Ottawa, Canada) at
room temperature and at a dose rate of 30 cGy/min.
Different irradiation times were used in order to administer
to the blood samples doses ranging from 1–10Gy. PCC slides
and galleries of captured PCC images were distributed
among the RENEB partners involved in the 1st intercompari-
son exercise. In the framework of the 2nd intercomparison
exercise for the PCC assay, blood samples were taken from
two healthy donors and irradiated at Bundesamt fuer
Strahlenschutz (BfS, Germany) with two different doses (0.85
and 2.7 Gy) using 137-Cs gamma rays with a dose rate of
0.478Gy/min. After a repair time of 2 h at 37 C the blood
samples were coded as RENEB 5 for the dose 0.85 Gy (Re5a,
Re5b) and RENEB 6 for the dose 2.7 Gy (Re6a, Re6b), to
ensure that the experiment was carried out under blind con-
ditions. The four irradiated and coded blood samples were
then sent to all participating laboratories to estimate the
dose delivered by means of the cell fusion PCC assay. It is
worth noticing that the above irradiation doses were
unknown to the participating laboratories and were only dis-
closed after the completion of the analysis and once all
results had been sent to the coordinator of the programme.
Cell fusion mediated premature chromosome
condensation
Human lymphocytes were separated from heparinized blood
samples using Biocoll separating solution (Biochrom). The
blood was carefully layered on top of an equal amount of
Biocoll in a test tube before centrifugation at 1900 rpm
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(400 g) for 20min. Collected lymphocytes (middle layer) were
washed with 10ml culture medium, centrifuged at 1500 rpm
(250 g) for 10min and kept in culture medium (RPMI-1640
supplemented with 10% FBS, 1% glutamine and antibiotics).
Lymphocytes isolated from 1ml of blood were used for 1–2
experimental points. Cell fusion and PCC induction using PEG
has been described previously (Pantelias and Maillie 1983;
Vyas et al. 1991; Darroudi et al. 1998a; Karachristou et al.
2015; Sebastia et al. 2015). Briefly, mitotic CHO cells har-
vested from a 75 cm2 flask were used for 2–3 fusions.
Lymphocytes and mitotic CHO cells were mixed in serum-
free RPMI-1640 medium with Hepes in a 15ml round-bottom
culture tube in the presence of colcemid. After centrifugation
at 1000 rpm (100 g) for 6min, the supernatant was discarded
without disturbing the cell pellet, keeping the tubes always
inverted in a test tube rack on a paper towel in order to
drain the pellet from excess liquid. While holding the tubes
in an inverted position, 0.15ml of 45% (w/v) PEG (mol wt
1450, Sigma-Aldrich/serum-free RPMI 1640 with Hepes) was
injected forcefully against the cell pellet using a micropipette
and immediately after the tube was turned in an upright
position and held for about 1min. Subsequently, 1.5ml of
phosphate buffered saline (PBS) was slowly added, the tube
was shaken gently and the cell suspension was centrifuged
at 1000 rpm (100g) for 6min. The supernatant was discarded
and the cell pellet was resuspended gently in 0.7ml RPMI-
1640 complete growth medium with colcemid. To optimize
cell fusion when a low number of lymphocytes is available,
complete lymphocyte growth medium, containing 2% phyto-
hemagglutinin (PHA) and 10% FBS, was used (Pantelias &
Maillie 1983; Karachristou et al. 2015; Sebastia et al. 2015).
After 60–75min at 37 C, cell fusion and PCC induction was
completed. Afterwards, cells were treated with hypotonic
solution KCl (0.075 M), and fixed with methanol:glacial acetic
acid (3:1, v/v), following standard cytogenetic procedures
with centrifugation at 200g. Chromosome spreads were pre-
pared, air-dried slides and stained with 3% Giemsa solution.
The PCC fragments per cell in excess of 46 PCC were scored
for each experimental point using light microscopy and the
analysis was greatly facilitated by an image analysis system
(Ikaros MetaSystems, Germany).
Centromeric and telomeric staining with PNA probes
Staining of centromeres and telomeres in lymphocyte PCC
(C/T FISH staining) was performed using the Q-FISH tech-
nique with a FAM-labeled PNA probe, specific for telomere
sequences (TelC-FAM), and a Cy3-labeled PNA probe, specific
for centromere sequences (Cent-Cy3) (both from Panagene,
Daejon, South Korea). Briefly, the slides were kept in an oven
at 60 C for at least 1 h, washed in phosphate buffered saline
(PBS) solution for 15min, fixed in formaldehyde 4% solution
for 2min, washed again in PBS twice for 5min and digested
in a pre-warm pepsin solution (1mg/ml) for 3min at 37 C.
After three PBS washes, slides were washed and refixed,
dehydrated with 7%, 90 and 100% ethanol and air dried.
PNA probes for centromere and telomere staining were
applied, co-denaturated for 3min at 80 C and incubated for
2 h in a humidified chamber at room temperature in the
dark. After hybridization, slides were washed with 70%
Formamide, 1% Tris 1M pH7.2, 1% BSA 10%, H2O, twice for
15min, then in TBS/Tween 0.08% three times for 5min each,
dehydrated with 70, 90 and 100% ethanol series, and finally
counterstained with DAPI (1 lg/ml) and mounting medium.
Analysis and scoring criteria
Lymphocyte PCC spreads were located manually and their
analysis was facilitated by the use of a semi-automated
image analysis system (Ikaros, MetaSystems, Germany).
Specifically, the analysis of excess PCC fragments in lympho-
cyte PCC spreads stained with Giemsa was greatly facilitated
by the appearance of the PCC, which are lighter stained than
the CHO mitotic cells and, therefore, easily distinguished
Figure 1. Giemsa-stained PCC showing 46 single chromatid chromosomes in
non-irradiated G0-peripheral blood lymphocyte (A). Sixteen fragments in excess
of 46 PCC can be visualized in an irradiated lymphocyte with 4 Gy when ana-
lyzed shortly after exposure (B).
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from the mitotic chromosomes of the CHO cells (Figure 1). In
unirradiated lymphocytes, 45–46 elements were scored in PCC
spreads and, in order to calculate the frequency of excess PCC
fragments, this number was subtracted from the one obtained
in the irradiated lymphocyte PCC. Generally, a number of
20–30 PCC spreads was considered adequate for dose estima-
tion following a single exposure. When C/T staining with PNA
probes was applied, dicentrics plus centric ring chromosomes
were quantified accurately on the basis of the detection of
centromeric regions and telomeric sequences using the ISIS
FISH-imaging software (MetaSystems, Germany). Only PCC
spreads with 46 centromeres were analyzed.
Experimental design for dose assessment
intercomparisons
Two inter-laboratory exercises were designed and carried out
for dose assessment intercomparisons within the RENEB net-
work. In the 1st exercise four groups were involved (L0, L1,
L3, L5) with the task to harmonize and standardize the PCC
assay and unify the scoring criteria, in order to construct
dose-response calibration curves for dose assessment imme-
diately after accidental exposure. Specifically, the detailed
protocol established by L1 was shared with the RENEB part-
ners and four of them (L0, L1, L3 and L5) applied it for the
present study. In addition, scientists from L2, L6, L8, and L10,
as well as from other RENEB partners who where not directly
involved in this PCC task, have been also trained in L1
laboratory. Furthermore, coded PCC slides and/or coded irra-
diated blood samples, as well as galleries of captured images
for different doses, were shared among the RENEB partners
to be analyzed for intercomparison purposes. In the 2nd
exercise, 10 RENEB laboratories participated (L1, L2, L3, L4,
L5, L6, L7, L8, L9, L10) and the experimental design focused
on dose assessment in cases where blood samples become
available at points in time beyond 24 h post-exposure.
Results
1st inter-laboratory exercise
Unification of scoring criteria and generation of calibration data
for Giemsa-stained excess PCC fragments. For the 1st exercise,
three sets of experiments were performed. In the first experi-
ment, carried out in laboratory L1, peripheral blood lympho-
cytes were exposed to 0, 1, 2, 4 and 6Gy of gamma-rays and
the PCC assay was applied shortly after irradiation in order to
construct the ‘immediate’ dose-response curve. In lymphocyte
PCC obtained from non-irradiated blood, 46 distinct single
chromatid chromosomes were scored (Figure 1A). Following
an in vitro exposure of 4 Gy, 16 fragments in excess of 46 PCC
were scored on average when the PCC assay was used imme-
diately after exposure (Figure 1B).
Galleries of 10 captured PCC images per dose point
obtained by L1 were distributed among the four laboratories
participating in this exercise (L0, L1, L3, L5) for the gener-
ation of calibration data to be used during programmed
intercomparisons. The objective was to carry out a compara-
tive study within the RENEB network in order to unify scoring
criteria on the basis of analysis of galleries with PCC images
for different doses. The results obtained for c-rays-induced
fragments in excess of 46 PCC in G0-lymphocytes by the dif-
ferent scorers in each laboratory are presented in Figure 2.
The mean values of excess PCC derived from all scorers
and the different dose-response calibration curves
obtained yielded a linear dose response (Figure 2, black bold
line, a ¼ 3.9 and b¼0.12) with four excess PCC fragments/
cell/Gy on the average.
Dose estimates using coded PCC slides
The second set of experiments for dose assessment was
designed simulating an accident exercise. Peripheral blood
lymphocytes were exposed in vitro to different doses of
gamma-rays, 0, 0.5, 1, 2, 3, 4, 5 and 6Gy, and three slides per
dose point were coded and distributed among the participat-
ing laboratories. The objective was to perform a comparative
analysis within RENEB network for dose assessment on the
basis of analysis of coded PCC slides for different doses. Dose
estimates were obtained by the analysis of 20 lymphocyte
PCC spreads per coded slide by each scorer (Table 1).
Based on the analysis of 100 lymphocyte PCC spreads per
dose-point, a dose-response curve for c-rays induced frag-
ments in excess of 46 PCC in G0-lymphocytes was generated
by each participating lab, as shown in Figure 3.
Applicability of the PCC assay to detect the fraction of
undamaged/damaged lymphocytes in case of accidental partial
body exposure. The 3rd set of experiments was performed to
assess the applicability of the PCC assay for the detection of
the fraction of undamaged/damaged cells enabling thus
dose estimates in case of accidental partial body exposure.
Peripheral blood lymphocytes were exposed to two different
doses of 2 and 4Gy of gamma-rays. Each sample was mixed
with the same volume of unirradiated blood from the same
donor (ratio of 1:1) and PCC was performed for all samples.
Slides were coded and distributed among the four participat-
ing partners. The data obtained are presented in Table 2. On
the basis of the percentage of abnormal cells found (>46
PCC), the simple averages from the four participating
Figure 2. Comparative results obtained from the analysis of gamma-rays
induced excess PCC fragments in human lymphocytes for the construction of
‘immediate’ dose-response curves. (Mean curve in black bold line: linear, a ¼
3.9 ± 0.13 and b ¼ 0.12.) Same 10 digitally captured PCC images per dose-
point were sent to and scored by each laboratory [L0 and L1 one scorer each;
L3 two scorers, and L5 three scorers].
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laboratories were 49.7% for 2Gy and 53% for 4 Gy partial
body exposure.
2nd inter-laboratory exercise
Dose-response calibration curve for Giemsa-stained excess PCC
fragments at 24 h post-irradiation. In the 2nd intercomparison
exercise for the PCC assay, two galleries of PCC captured
images for each Re5a, Re5b and Re6a, Re6b irradiated blood
samples were distributed by L1 among all partners. The aim
was to perform an intercomparison between the different
groups as well as the different scorers in each group.
Towards this goal, L1 performed also the necessary experi-
ments to generate a calibration curve for radiation-induced
excess PCC fragments after a repair time period of 24 h
(Figure 4). This dose-response calibration curve was distrib-
uted among all participating laboratories. The laboratory L6
used its own calibration curve. All other laboratories that par-
ticipated in this PCC exercise used the dose-response calibra-
tion curve constructed at L1.
Dose estimation at 24 h post exposure in coded irradiated
blood samples on the basis of Giemsa-stained excess PCC frag-
ments. Tables 3 and 4 present the dose estimates obtained
by each participating laboratory for samples Re5a and Re5b
and Re6a and Re6b, respectively, on the basis of the yield of
Giemsa-stained excess PCC fragments/cell using the calibra-
tion curve for 24-h repair period at 37 C from lab L1
(Figure 4). Lab L6 used its own calibration curve.
Table 1. Dose assessments (in vitro)a obtained by the analysis of 20 lympho-
cyte PCC spreads per coded slide by each laboratory group.
Group Actual dose (Gy) Estimated dose(Gy) 95% LCL(Gy) 95% UCL(Gy)
L0 0 0 0 0
0.5 0.48 0.42 0.56
1.0 0.9 0.8 1.0
2.0 1.8 1.6 2.0
3.0 2.7 2.4 3.0
4.0 3.5 3.0 4.0
5.0 4.4 3.9 5.0
6.0 5.1 4.5 5.8
L1 0 0 0 0
0.5 0.62 0.55 0.7
1.0 1.1 1.0 1.3
2.0 1.9 1.7 2.1
3.0 2.8 2.5 3.2
4.0 3.5 3.0 4.1
5.0 4.2 3.7 4.8
6.0 5.1 4.5 5.7
L3 0 0 0 0
0.5 0.2 0.1 0.3
1.0 0.5 0.4 0.6
2.0 1.2 1.1 1.4
3.0 1.7 1.5 1.9
4.0 1.7 1.5 1.9
5.0 2.8 2.5 3.2
6.0 3.6 3.2 4.1
L5 0 0 0 0
0.5 0.58 0.5 0.65
1.0 0.8 0.7 0.9
2.0 1.3 1.1 1.5
3.0 2.1 1.8 2.4
4.0 3.0 2.6 3.4
5.0 3.6 3.1 4.0
6.0 5.3 4.7 5.9
aThe dose estimates were obtained using a calibration curve generated at L0
following the irradiation of human lymphocytes (from 10 donors) to X-rays
(200 kV, 4mA). The dose response curve was found to be linear (a ¼ 4.1 and
b ¼ 0.07). LCL: lower confidence limit; UCL: upper confidence limit.
Figure 3. Gamma-rays induced fragments in excess of 46 PCC following irradi-
ation to doses up to 6 Gy. (Mean curve in black bold line: linear, a¼ 3.3 ± 0.16
and b¼0.26) Sets of coded replicate slides were sent to and analysed by
each laboratory.
Figure 4. Dose-response curve for excess lymphocyte PCC fragments at 24 h
post-irradiation repair time and for doses up to 9 Gy (Linear, a¼ 1.2 ± 0.029
b¼0.082). Mean values ± SD are calculated from three independent
experiments.
Table 2. Estimation of the fraction of damaged/undamaged cells using the
PCC assay in human lymphocytes exposed to gamma-rays and mixed with
unirradiated lymphocytes (1:1).
Group
dose (Gy)
Fraction
irradiated (%)
Normal
cells
Abnormal
cells (%)
Induced
PCC/cell in
abnormal cells
L0a
2 50 50 50 7.8
4 50 40 60 15.0
L1b
2 50 51 49 7.9
4 50 53 47 14.7
L3c
2 50 50 50 4.1
4 50 55 45 8.2
L5d
4 50 40 60 10.0
aL0 and bL1 groups analyzed 20 and 40 cells, respectively. cL3 and dL5 groups
scored 20 cells each. The dose estimates obtained on the basis of observed
PCC-frequencies among aberrant cells, and they were 1.8 Gy (LCL¼ 1.6 Gy, and
UCL¼ 2.1 Gy); and 3.4 Gy (lower confidence limit [LCL]¼ 3.1 Gy, and upper
confidence limit [UCL]¼ 3.8 Gy), for lymphocytes samples exposed to 2 and
4 Gy, respectively.
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Laboratory performance of RENEB participating groups
Z-value, intercomparison. The z-test was used to determine
the laboratory performance. A z-score for each estimated
dose was calculated, allowing the classification of the partici-
pants results into satisfactory (j z j  2), questionable
(2< j z j< 3) and unsatisfactory (j z j  3) (International Atomic
Energy Agency [IAEA] 2011). Figure 5 shows the z-scores for
all estimated doses based on the Re5a and Re5b samples. A
tendency for overestimation of the dose (z> 0) for Re5 sam-
ples is observed. Nearly all labs are satisfactory in their
reported values. For Re6a and Re6b all labs are satisfactory in
their reported values as shown in Figure 6.
Dose assessment in coded irradiated blood samples at 24 h
post-irradiation on the basis of dicentric analysis using C/T
staining with PNA probes and FISH in G0-lymphocytes. Dose
assessment in coded irradiated blood samples (Re5 and Re6)
was carried out by means of the analysis of dicentric chromo-
somes in G0-lymphocyte PCC at 24 h post-irradiation time-
point. For this purpose, C/T staining with PNA probes and
FISH was applied to G0-lymphocyte PCC spreads in order to
Table 3. Dose estimates obtained by each participating laboratory for samples Re5a, Re5b (0.85 Gy) on the basis of the yield of Giemsa-
stained excess PCC fragments/cell using the calibration curve for 24-h repair period at 37 C constructed by Lab L1. Lab L6 used its own
calibration curve.
Dose estimates for Re5
10 cells 15–20 cells 30–40 cells
Code
Excess PCC
fragments/cell Dose (Gy)
Excess PCC
fragments/cell Dose (Gy)
Excess PCC
fragments/cell Dose (Gy) Lab ID
Re5a 1.20 1.05 1.45 1.20 1.23 1.07 L1
1.50 1.24 1.60 1.32 1.60 1.32 L2
1.00 0.89 0.85 0.76 0.90 0.64 L3
0.90 0.80 1.00 0.89 0.95 0.85 L4
1.20 1.05 1.15 1.01 1.06 0.86 L5
1.40 0.78 1.80 1.01 1.40 0.78 L6
1.10 0.97 1.15 1.01 1.13 1.00 L7
1.00 0.89 1.40 1.15 1.27 1.10 L8
0.70 0.64 0.86 0.77 1.10 0.97 L9
0.70 0.64 0.80 0.72 0.86 0.77 L10
Re5b 1.00 0.89 1.25 1.09 1.10 0.97 L1
1.80 1.49 1.70 1.40 1.70 1.40 L2
0.80 0.72 0.90 0.80 1.00 0.71 L3
0.80 0.72 0.70 0.64 0.75 0.69 L4
1.30 1.13 1.10 0.97 0.89 0.80 L5
1.80 1.01 1.50 0.84 1.30 0.73 L6
1.00 0.89 0.96 0.86 1.05 1.00 L7
0.93 0.83 1.40 1.15 1.07 0.95 L8
1.00 0.89 0.67 0.62 0.87 0.78 L9
0.80 0.72 0.93 0.83 1.00 0.89 L10
Table 4. Dose estimates obtained by each participating laboratory for samples Re6a, Re6b (2.7 Gy) on the basis of the yield of Giemsa-
stained excess PCC fragments/cell using the calibration curve for 24-h repair period at 37 C constructed by Lab L1. Lab L6 used its own
calibration curve.
Dose estimates for Re6
10 cells 15–20 cells 30–40 cells
Code
Excess PCC
fragments/cell Dose (Gy)
Excess PCC
fragments/cell Dose (Gy)
Excess PCC
fragments/cell Dose (Gy) Lab ID
Re6a 4.30 3.59 3.75 3.14 3.63 3.04 L1
3.80 3.14 3.90 3.22 3.93 3.24 L2
3.10 2.61 2.70 2.28 2.57 2.01 L3
3.60 3.02 2.85 2.41 2.80a 2.37a L4
3.40 2.85 2.95 2.49 3.08 2.52 L5
5.24 2.93 5.30 2.96 5.75 3.22 L6
3.43 2.88 3.19 2.67 3.84 3.00 L7
3.60 3.02 3.87 3.18 3.38 2.78 L8
2.90 2.45 2.87 2.42 2.75 2.32 L9
2.90 2.45 2.67 2.26 2.85 2.41 L10
Re6b 4.00 3.35 3.30 2.77 3.40 2.85 L1
4.30 3.55 4.20 3.52 4.10 3.38 L2
2.70 2.28 2.50 2.12 2.59 2.04 L3
2.30 1.96 2.80 2.37 2.75a 2.01a L4
3.90 3.27 3.50 2.94 3.38 2.78 L5
5.10 2.85 5.60 3.13 5.84 3.27 L6
3.31 2.78 3.22 2.71 2.84 2.50 L7
3.90 3.27 3.64 2.98 3.40 2.85 L8
3.10 2.61 2.93 2.47 3.14 2.65 L9
2.90 2.45 2.88 2.43 3.07 2.59 L10
aBased on their own PCC preparations.
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score accurately the dicentric chromosomes and quantify
their frequency on the basis of the detection of centromeric
regions and telomeric sequences (Figure 7). Indeed, using
the ISIS FISH-imaging software (MetaSystems, Germany) and
the inverted grey scale mode as shown in Figure 7(A), two
dicentric chromosomes T dic (True dicentric) and F dic
(False dicentric) can be visualized. However, in addition to
the centromeric sequences, the staining of telomeric sequen-
ces is also needed in order to enable the detection of true
dicentrics accurately, as shown in Figure 7(B).
Table 5 presents the dose estimates obtained with dicen-
tric analysis in G0-lymphocyte PCC, using Telomere-
Centromere staining with peptide nucleic acid (PNA) probes,
for both samples Re5 and Re6. The three participating labora-
tories were L1, L2 and L6.
Discussion
The RENEB network is organized with the aim to perform
rapid individualized dose estimates in case of large-scale
radiological emergencies. The rationale for triage biodosime-
try is to set a reasonable cut-off of dose absorbed, below
which treatment is not expected to impact survival rates and
above which treatment is necessary to improve survival rates.
This cut-off is generally set at 2Gy, but this threshold could
be plausibly set higher, e.g. 3 Gy, if the numbers of affected
individuals were beyond the capabilities of the medical sys-
tem (Grace et al. 2010; Rea et al. 2010, Flood et al. 2011;
Swartz et al. 2014; Kulka et al. 2015). Essentially, the aim in
triage biodosimetry is to classify the exposed individuals, as
rapidly as possible, into three categories: those who have suf-
fered radiation injury, for whom immediate medical interven-
tion could mean the difference between life and death;
those with intermediate doses, for whom medical
Figure 5. Z-scores for estimated doses based on 30–40 cells from samples Re5a
and Re5b. Dashed lines indicate boundaries of classification according to z-
scores.
Figure 6. Z-scores for estimated doses based on 30–40 cells from samples Re6a
and Re6b. Dashed lines indicate boundaries of classification according to z-
scores.
Figure 7. G0-lymphocyte PCC visualized by means of inverted grey scale mode
(ISIS-FISH software, MetaSystems) following a 24 h post-irradiation repair period
showing two possible dicentric chromosomes (A). True dicentric chromosomes
(T dic) can be detected accurately only by means of C/T FISH staining with PNA
probes (B). The presence of telomeric staining (Tel-FAM, green) between the
two centromeres (Cent-Cy3, red), as shown in this Figure (B), confirms undoubt-
edly a false dicentric (F dic).
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intervention will be necessary to mitigate the short, medium
and long-term effects of exposure, and the ‘worried well’
with probable low doses, for whom no deterministic effects
are expected but long-term monitoring may be required
(Ainsbury & Barquinero 2009). In the present work, inter-
laboratory dose assessment intercomparisons were per-
formed within the RENEB network for the harmonization,
standardization and optimization of the cell fusion PCC assay
by the analysis of excess PCC fragments or dicentrics directly
in unstimulated G0-peripheral blood lymphocytes. Towards
this goal, two inter-laboratory exercises were designed and
carried out.
The 1st exercise aimed to the harmonization of the PCC
assay and the unification of scoring criteria, in order for all
the RENEB partners involved to be able to construct dose-
response calibration curves for dose assessment, immediately
after accidental exposure. Interestingly, in their analyses of
control unirradiated samples (Figure 1A), no aberrant cell
with more than 46 PCC was observed/reported. Also, in irra-
diated blood samples with a dose as low as 0.5 Gy, no nor-
mal cell with 46 PCC was observed. This indicates that with
the PCC assay, even the analysis of few cells allows the dis-
crimination between unexposed and exposed individuals at a
dose level of 0.5 Gy (whole body irradiation). The results
presented in Figure 2 show that dose-response calibration
curves for Giemsa-stained excess PCC fragments, constructed
by the different partners, are mostly in good agreement. The
mean values of excess PCC fragments derived from all scor-
ers yielded on the average a linear dose response with 4
excess PCC fragments/cell/Gy (e.g. see Figure 1B). Similar
data were obtained by the L0 and L1 groups when analyzing
PCC-images for different doses (Figure 2). At L5 and L3
(Figure 2), three and two persons scored the images, respect-
ively. Results obtained from one of the scorers at L5 for all
doses were similar to those obtained by the L0 and L1
groups. Overall, there was no difference between different
scorers, at lower doses and differences appear at higher
doses (higher than 2Gy). However, the mean value of PCC
derived from all scorers yielded a linear dose response curve
(Figure 2, black bold line: linear, a ¼ 3.9 ± 0.13 and b ¼
0.12) and approximately 4 breaks/cell/Gy was obtained.
The dose estimates shown in Table 1 were obtained from
the analysis of coded PCC slides by the RENEB partners in
the 1st inter-laboratory exercise, through the analysis of only
20 lymphocytes per slide by each scorer using calibration
data from the set of images produced by L1 and distributed
among the participating laboratories. Differences in dose esti-
mates were observed among participating laboratories, as
well as between the different scorers, particularly for doses
above 2Gy, as shown in Figure 3. However, the mean dose
estimates, 3.5–4 fragments/cell/Gy (Figure 3) and shape (lin-
ear, a¼ 3.3 ± 0.16 and b¼0.26) of the dose-response curve
were close to those expected. The dose assessment was per-
formed based on an existing calibration curve (a¼ 4.1 and b
¼ 0.07) generated at L0 using peripheral blood lymphocytes
from 10 donors exposed to X-rays (200 kV, 4mA). The data
revealed a positive correlation between expected and esti-
mated doses of irradiation, for all doses at 95% confidence
limits while, in some cases, the doses of exposure were
underestimated. The mean values especially for doses of
2–5Gy were 20–30% lower than the expected ones (Table 1
and Figure 3).
Regarding the ability of the PCC assay to detect the frac-
tion of undamaged/damaged lymphocytes in case of acci-
dental partial body exposure, the data from all groups were
in good agreement with each other, with a simple average
of 49.7 and 53% detected for doses of 2 and 4Gy, respect-
ively, versus the actual ratio of 50%. Furthermore, the yield
of radiation-induced excess PCC fragments in aberrant cells
was successfully used to estimate the exposure dose
(Table 2). In fact, the data by L0 and L1 showed 1.8 Gy (lower
confidence limit [LCL]¼ 1.6 Gy and upper confidence limit
[UCL]¼ 2.1 Gy) for a sample exposed to 2Gy (and mixed 50%
with unirradiated blood lymphocytes), and 3.4 Gy (LCL
¼3.1 Gy and UCL¼ 3.8 Gy) for the sample exposed to 4Gy.
The estimates derived by the L3 and L5 groups showed
lower doses.
Laboratories specialized in biological dosimetry which use
the PCC assay should construct immediate dose-response
calibration curves, mainly for X-rays and gamma radiation
sources such as Co-60 or Cs-137, and use them for dose esti-
mation when blood samples are received in the laboratory
immediately after accidental exposure. Most importantly,
though, appropriate dose-response curves for Giemsa stained
excess PCC fragments or dicentrics with C/T staining must be
also constructed for dose assessment, since blood samples
Table 5. Dose estimates obtained by three participating laboratories (L1, L2 and L6) based on dicentric analysis in G0-lymphocyte PCC,
using centromere-telomere staining with peptide nucleic acid (PNA) probes, for both samples Re5 (0.85 Gy) and Re6 (2.7 Gy).
Whole body dose estimate and 95% confidence limits
20 cells 30 cells 50 cells
Code Dose (Gy) LCL UCL Dose (Gy) LCL UCL Dose (Gy) LCL UCL
Participating
laboratory
Re5a 0.78 0.04 1.96 0.98 0.30 1.89 0.77 0.26 1.46 L1
Re5a 1.8 0.95 2.78 1.5 0.86 2.34 1.5 0.95 2.08 L2
Re5a 0.7 0.5 0.9 0.9 0.7 1.2 1 0.7 1.2 L6
Re5b 1.3 1.1 1.7 1.4 1.1 1.8 1 0.8 1.3 L6
Re6a 3.66 2.72 4.70 3.12 2.36 3.96 3.29 2.70 3.93 L1
Re6a 3.3 2.48 4.29 2.9 2.28 3.74 2.7 2.17 3.29 L2
Re6a 2.4 1.9 2.9 2.3 1.8 2.7 2.3 1.8 2.7 L6
Re6b 2.8 2.2 3.3 2.5 2 3 2.2 1.7 2.6 L6
LCL: lower confidence limit; UCL: upper confidence limit.
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most likely become available at points in time beyond 24 h
post-exposure and repair of DNA damage that may have
occurred during this time interval has to be taken into
account. Towards this goal, the 2nd exercise was designed to
construct first a dose-response curve at 24 h post-exposure
(Figure 4) and then use it for dose assessment of the coded
irradiated blood samples Re5 and Re6. The dose estimates
obtained by the different RENEB partners following blood
sample irradiation at BfS with 0.85Gy (Re5) and 2.7 Gy (Re6)
(Oestreicher et al. 2016), were mostly in good agreement
(Tables 3 and 4). The use of the z-test on the performance of
the different laboratories involved showed a tendency for
overestimation (z> 0) for the samples Re5a and Re5b irradi-
ated with 0.85Gy (Figure 5). However, based on the reported
dose estimates for samples Re6a and Re6b irradiated with
2.7 Gy, z-score for all laboratories indicated a satisfactory per-
formance (Figure 6).
Dose estimation for the irradiated coded samples Re5 and
Re6 was also obtained following C/T FISH staining for scoring
dicentric and centric ring chromosomes in G0-lymphocyte PCC
(Table 5). Three laboratories (L1, L2 and L6) participated and
used linear-quadratic dose-response curves for PCC-dicentric
and centric ring chromosomes as well as the readily available
specialized software ‘CABAS’ or ‘Dose Estimate’ (IAEA 2011).
The results reported are in good agreement with those
obtained scoring Giemsa-stained excess PCC fragments
(Tables 3 and 4). However, although the C/T staining with pep-
tide nucleic acid (PNA) probes enables a rapid detection of
dicentrics and centric ring chromosomes in lymphocyte PCC
with accuracy and ease, the procedure is still laborious, expen-
sive and time-consuming when compared to the analysis of
Giemsa-stained excess PCC fragments. Consequently, the ana-
lysis of Giemsa-stained PCC fragments may provide an inex-
pensive and quick alternative solution, since scoring of even
only 10 PCC spreads provides satisfactory dose estimates and
comparable results to those obtained from the analysis of
15–20 or 30–40 spreads for both coded doses (Tables 3 and
4). Indeed, Karachristou et al. (2015) reported that using the
t-test, no statistically significant difference was found between
the doses estimated by the C/T-PCC-FISH method or the
method based on Giemsa-stained excess PCC fragments when
10 cells were scored (p¼ .981), when 20 cells were scored
(p¼ .731) or when 30 cells were scored (p¼ .757).
In summary, the dose assessment intercomparisons within
the RENEB network with G0-lymphocyte PCC were in good
agreement and showed that the PCC assay is a quick and
reliable methodology for triage biodosimetry scoring either
excess PCC fragments or dicentrics and centric rings in G0-
lymphocytes. Indeed, this technique has the potential to
deliver data for dose assessment in a significant shorter
period of time than any other biological assay being used
currently, as only few cells need to be analyzed in order to
detect exposed individuals. PCC assay can as well accurately
discriminate between whole- and partial-body exposure and
this feature is of great importance for designing a better
strategy for the treatment of individuals exposed to life-
threatening high doses of radiation. Moreover, the analysis of
Giemsa-stained excess PCC-fragments is a simple and cost-
effective alternative to the C/T-PCC-FISH method that enables
a rapid estimation of absorbed dose within 2 h. In addition,
its automation could potentially increase throughput and
scoring objectivity of the PCC assay.
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